Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
TP1856 | Colivelin | 867021-83-8 | 96.56% |
|
Colivelin is a neuroprotective peptide and activator of STAT3. Colivelin is a hybrid peptide synthesized to enhance the neuroprotective effects of humanin (HN). | ||||
TN1027 | β-Amyrin | 559-70-6 | 96.49% |
|
β-Amyrin (beta-Amyrin) has antiviral, hepatoprotective, antinociceptive, anti-inflammatory | ||||
TP1359L | Amyloid β Peptide (42-1)(human) acetate | 95.20% |
|
|
Amyloid β Peptide (42-1)(human) acetate is the inactive form of Amyloid β Peptide (1-42). Amyloid β Peptide (42-1)(human) acetate is a 42-amino acid peptide whic... | ||||
T28441 | PPI-1019 | 290828-45-4 | 95.16% |
|
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). | ||||
T0795 | Rutin | 153-18-4 | 95% |
|
Rutin (Quercetin 3-O-rutinoside), a flavonoid, has a variety of biological activities including antiallergic, anti-inflammatory, antiproliferative, and anticarci... | ||||
T14673 | BMS 299897 | 290315-45-6 | 100% |
|
BMS 299897 is a sulfonamide γ-secretase inhibitor. It has an IC50 of 7 nM for Aβ production inhibition in HEK293 cells stably overexpressing amyloid precursor pr... | ||||
TP1866L | β-amyloid 1-11 acetate(190436-05-6 free base) | TP1866L | 100% |
|
β-amyloid 1-11 acetate is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease. | ||||
T22204 | LY 2389575 hydrochloride | 885104-09-6 | 100% |
|
LY2389575 hydrochloride is an mGlu3 negative allosteric modulator (NAM) that is selective and non-competitive, with an IC50 value of 190 nM. LY2389575 hydrochlor... | ||||
T7562 | β-Amyloid (31-35) | 149385-65-9 | 100% |
|
β-Amyloid (31-35) (β-Amyloid 31-35) is the shortest sequence of native Amyloid-β peptide. | ||||
T7905 | PBD-150 | 790663-33-1 | 100% |
|
PBD-150 is an inhibitor of human glutaminyl cyclase (hQC) Y115E-Y117E variant( ki : 490 nM) | ||||
TQ0026 | MDR-1339 | 1018946-38-7 |
|
|
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation. | ||||
T2873 | Ginsenoside Rg2 | 52286-74-5 |
|
|
Ginsenoside Rg2 (Chikusetsusaponin I) is one of the major active components of ginseng, act as an NF-κB inhibitor. | ||||
T22932L | LPYFD-NH2 acetate |
|
||
LPYFD-NH2 acetate shows some inhibitory effect on the aggregation of Abeta(1-42). | ||||
TN1341 | 8-Deoxygartanin | 33390-41-9 |
|
|
8-Deoxygartanin is a butyrylcholinesterase (BChE) selective inhibitor, it exhibits significant inhibition of self-induced α2-amyloid (Aα2) aggregation, it has mu... | ||||
TP1935L1 | RAGE antagonist peptide acetate | TP1935L1 | 98% |
|
RAGE antagonist peptide acetate is an advanced antagonist of glycation end products (RAGE). RAGE antagonist peptide acetate possesses anti-tumor and anti-inflamm... | ||||
T77042 | Aducanumab | 1384260-65-4 | 98% |
Aducanumab
|
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brai... | ||||
T77054 | Lecanemab | 1260393-98-3 | 98% |
Lecanemab
|
Lecanemab (BAN-2401), an IgG1 monoclonal antibody targeting soluble aggregated amyloid beta (Aβ), demonstrates efficacy across Aβ oligomers, protofibrils, and in... | ||||
T7680 | GSNKGAIIGLM(131602-53-4(free base)) | T7680 | 98% |
|
GSNKGAIIGLM(131602-53-4(free base)) (Amyloid beta-peptide(25-35)) is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide. | ||||
T38469 | (Rac)-Z-Phe-Phe-FMK | 108005-94-3 | 98% |
|
(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes . |